Style
CoreTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | MBX Biosciences Inc(MBX) | 800,173 | $44.2M | 4.52% |
| 2 | ELI Lilly & Co(LLY) | 35,000 | $42.0M | 4.30% |
| 3 | CVS Health Corp(CVS) | 391,791 | $40.5M | 4.15% |
| 4 | Dexcom Inc(DXCM) | 534,767 | $36.0M | 3.69% |
| 5 | PTC Therapeutics Inc(PTCT) | 435,691 | $35.5M | 3.64% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Industrials | 0% | 0.82% | +0.82% |
| Healthcare | 93.82% | 93.1% | -0.72% |
| Arcus Biosciences Inc(RCUS) |
| 919,266 |
| $28.3M |
| 2.90% |
| 7 | Structure Therapeutics Inc(GPCR) | 485,661 | $26.1M | 2.67% |
| 8 | Viridian Therapeutics Inc(VRDN) | 1,377,576 | $25.3M | 2.59% |
| 9 | Agios Pharmaceuticals Inc(AGIO) | 669,046 | $24.8M | 2.54% |
| 10 | Inhibrx Biosciences Inc(INBX) | 256,950 | $24.3M | 2.49% |
| Unclassified | 6.18% | 6.08% | -0.1% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 25.77% | 31.84% | +6.07% |
| Mid Cap | 27.83% | 29.14% | +1.31% |
| Large Cap | 32.96% | 23.29% | -9.67% |
| Mega Cap | 4.99% | 6.7% | +1.71% |
| Unclassified | 6.18% | 6.08% | -0.1% |
| Micro Cap | 2.26% | 2.95% | +0.69% |
Quarter-over-quarter position changes